Libros bestsellers hasta 50% dcto  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Egfr-Directed Therapy in Lung Cancer (Elements in Molecular Oncology) (in English)
Type
Physical Book
Language
English
Pages
75
Format
Paperback
Dimensions
22.9 x 15.2 x 0.2 cm
Weight
0.07 kg.
ISBN13
9781009342308
Edition No.
1
Categories

Egfr-Directed Therapy in Lung Cancer (Elements in Molecular Oncology) (in English)

So Yeon Kim (Author) · Daniel B. Costa (Author) · Daisuke Shibahara (Author) · Cambridge University Press · Paperback

Egfr-Directed Therapy in Lung Cancer (Elements in Molecular Oncology) (in English) - Kim, So Yeon ; Costa, Daniel B. ; Shibahara, Daisuke

New Book

$ 19.68

$ 22.00

You save: $ 2.32

11% discount
  • Condition: New
It will be shipped from our warehouse between Monday, May 27 and Tuesday, May 28.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Egfr-Directed Therapy in Lung Cancer (Elements in Molecular Oncology) (in English)"

Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a clinically important driver alteration affecting approximately one-third of lung cancer patients. Treatments for EGFR-exon 19 deletion and exon 21 L858R NSCLC have evolved over the last decade from first-generation reversible tyrosine kinase inhibitors (TKI) to third-generation irreversible TKIs, of which osimertinib has been the widely accepted as first-line therapy. Despite survival improvement seen with osimertinib and its efficacy against acquired T790M mutation, resistance through on-target and off-target pathways eventually develop. This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and discusses past, current, and future treatment options in the metastatic, neoadjuvant, and adjuvant settings. It describes the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon exon 18 (G719X), 20 (S768I), and 21 (L861Q) mutations. It also outlines the promising clinical applications of circulating tumor DNA (ctDNA).

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews